Supply Chain
Long wait times, crowded waiting rooms, and frustrated staff are often symptoms of inefficient workflows driven by physical space constraints.…
Product benchmarking can be based on simple ratios related to volume, price and geography. However, in purchased services, ratio benchmarks provide no insight into the quality of a service provided, according to Chris Gormley, CEO of Guilford, Conn.-based Medpricer.
Japanese drugmaker Sawai Pharmaceutical Co., will purchase Minneapolis-based Upsher Smith's generic drug business for $1 billion, reports Bloomberg.
The Food and Drug Administration on Friday approved an expanded use of Novartis' cancer drug Zykadia.
The Food and Drug Administration approved Glenmark Pharmaceuticals' generic hypertension treatment, nebivolol, reports Business Standard.
The drug and health products industry is boosting lobbying efforts amid a national sentiment to lower prescription drug prices, reports The New York Times.
Food and Drug Administration Commissioner Scott Gottlieb, MD, testified Thursday before the House Appropriations Subcommittee, discussing President Donald Trump's proposed budget, the FDA hiring freeze and strategies to lower drug prices, reports Regulatory Focus.
Supply chain managers should participate in daily scheduling huddles with surgical teams to sequence cases and map out necessary resources for predictable surgical schedules," according to Tom Fox, a managing director at healthcare consulting firm Nova Strategies.
Deutsche Post DHL Group on Wednesday launched software that uses machine learning algorithms and natural language processing to predict supply chain risks.
Nevada seeks to better regulate the cost of prescription drugs with a new bill, reports Business Insider.
GW Pharmaceuticals' experimental epilepsy drug, derived from marijuana, may be the first drug of its kind to earn regulatory approval, reports Business Insider.